BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7859006)

  • 21. Barrett's esophagus can and does regress after antireflux surgery: a study of prevalence and predictive features.
    Gurski RR; Peters JH; Hagen JA; DeMeester SR; Bremner CG; Chandrasoma PT; DeMeester TR
    J Am Coll Surg; 2003 May; 196(5):706-12; discussion 712-3. PubMed ID: 12742201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathophysiology of Barrett's esophagus.
    Chandrasoma P
    Semin Thorac Cardiovasc Surg; 1997 Jul; 9(3):270-8. PubMed ID: 9263345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Barrett's esophagus: the long and the short of it.
    Nandurkar S; Talley NJ
    Am J Gastroenterol; 1999 Jan; 94(1):30-40. PubMed ID: 9934728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Barrett's esophagus.
    Spechler SJ
    Gastroenterologist; 1994 Dec; 2(4):273-84. PubMed ID: 7866734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Barrett's esophagus and risk of esophageal adenocarcinoma.
    Cossentino MJ; Wong RK
    Semin Gastrointest Dis; 2003 Jul; 14(3):128-35. PubMed ID: 14653412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical implications of Barrett's esophagus.
    Crooks GW; Lichtenstein GR
    Arch Intern Med; 1996 Oct; 156(19):2174-80. PubMed ID: 8885815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short and ultrashort Barrett's esophagus--what does it mean?
    Spechler SJ
    Semin Gastrointest Dis; 1997 Apr; 8(2):59-67. PubMed ID: 9109693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mucin expression and proliferating cell index of esophageal Barrett's adenocarcinoma.
    Yamamoto S; Kijima H; Hara T; Chino O; Shimada H; Tanaka M; Inokuchi S; Makuuchi H
    Int J Mol Med; 2005 Sep; 16(3):375-80. PubMed ID: 16077942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relationship between gastroesophageal reflux disease and its complications with Barrett's esophagus.
    Eisen GM; Sandler RS; Murray S; Gottfried M
    Am J Gastroenterol; 1997 Jan; 92(1):27-31. PubMed ID: 8995932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Barrett's esophagus].
    Kouzu T; Yoshimura S; Onuma EK; Hishikawa E; Arima M
    Nihon Geka Gakkai Zasshi; 1998 Sep; 99(9):552-7. PubMed ID: 9842539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytokeratin 7 and 20 expression in intestinal metaplasia of the distal oesophagus: relationship to gastro-oesophageal reflux disease.
    Shearer C; Going J; Neilson L; Mackay C; Stuart RC
    Histopathology; 2005 Sep; 47(3):268-75. PubMed ID: 16115227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Review article: management of oesophageal adenocarcinoma -- control of acid, bile and inflammation in intervention strategies for Barrett's oesophagus.
    Jankowski JA; Anderson M
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 5():71-80; discussion 95-6. PubMed ID: 15456468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
    O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
    Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What's new in columnar lined esophagus (Barrett's metaplasia)?
    Tadiparthi R; Bansal A; Sharma P
    Curr Opin Gastroenterol; 2008 Jul; 24(4):516-20. PubMed ID: 18622169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High power setting argon plasma coagulation for the eradication of Barrett's esophagus.
    Pereira-Lima JC; Busnello JV; Saul C; Toneloto EB; Lopes CV; Rynkowski CB; Blaya C
    Am J Gastroenterol; 2000 Jul; 95(7):1661-8. PubMed ID: 10925965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Association between symptomatic gastroesophageal reflux and Barrett's esophagus].
    Trujillo-Benavides OE; Baltazar-Montúfar P; Angeles-Garay U; Ramírez-Mendoza P; Navarro-García AM; Paredes-Cruz E; Méndez del Monte R; Guerrero-Hernández M
    Rev Gastroenterol Mex; 2005; 70(1):14-9. PubMed ID: 16170957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CagA-positive strains of Helicobacter pylori may protect against Barrett's esophagus.
    Vaezi MF; Falk GW; Peek RM; Vicari JJ; Goldblum JR; Perez-Perez GI; Rice TW; Blaser MJ; Richter JE
    Am J Gastroenterol; 2000 Sep; 95(9):2206-11. PubMed ID: 11007219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased c-myb mRNA expression in Barrett's esophagus and Barrett's-associated adenocarcinoma.
    Brabender J; Lord RV; Danenberg KD; Metzger R; Schneider PM; Park JM; Salonga D; Groshen S; Tsao-Wei DD; DeMeester TR; Hölscher AH; Danenberg PV
    J Surg Res; 2001 Aug; 99(2):301-6. PubMed ID: 11469901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Barrett's esophagus and the presence of Helicobacter pylori.
    Henihan RD; Stuart RC; Nolan N; Gorey TF; Hennessy TP; O'Morain CA
    Am J Gastroenterol; 1998 Apr; 93(4):542-6. PubMed ID: 9576445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Barrett's esophagus and adenocarcinoma of the gastroesophageal junction: a pathologic perspective.
    Tang LH; Klimstra DS
    Surg Oncol Clin N Am; 2006 Oct; 15(4):715-32. PubMed ID: 17030269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.